Viewing Study NCT00439361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-01-31 @ 7:33 AM
Study NCT ID: NCT00439361
Status: COMPLETED
Last Update Posted: 2012-07-09
First Post: 2007-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hodgkin Lymphoma View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hodgkin Lymphoma View
None HL View
None Relapsed Classical Hodgkin Lymphoma View
None Refractory View
None Lymphoma View
None Nodular sclerosis View
None Mixed cellularity View
None Lymphocyte-rich classical HL View
None Bortezomib View
None Velcade View
None LDP-341 View
None MLN341 View
None PS-341 View
None Carboplatin View
None Paraplatin View
None Etoposide View
None VePesid® View
None Ifosfamide View
None Mesna View
None Mesnex View
None ICE View